Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 10:07 am Purchase |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
RTW Investments, LP | 2,980,482 6.900% |
2,980,482 (New Position) |
Filing History |
| 2023-02-14 10:07 am Purchase |
2022-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
RTW Investments, LP | 5,106,341 9.900% |
2,243,143 (+78.34%) |
Filing History |
| 2023-02-14 10:06 am Purchase |
2022-12-31 | 13G | Immunic, Inc. IMUX |
RTW Investments, LP | 3,861,290 8.700% |
2,145,820 (+125.09%) |
Filing History |
| 2023-02-14 10:06 am Sale |
2022-12-31 | 13G | La Jolla Pharmaceutical Company LJPC |
RTW Investments, LP | 0 0.000% |
-2,590,932 (Position Closed) |
Filing History |
| 2023-02-14 10:06 am Sale |
2022-12-31 | 13G | IVERIC bio, Inc. ISEE |
RTW Investments, LP | 821,288 0.600% |
-5,901,336 (-87.78%) |
Filing History |
| 2023-02-14 10:06 am Purchase |
2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
RTW Investments, LP | 3,354,303 7.200% |
90,272 (+2.77%) |
Filing History |
| 2023-02-14 10:05 am Purchase |
2022-12-31 | 13G | Oyster Point Pharma, Inc. OYST |
RTW Investments, LP | 2,304,977 8.600% |
246,473 (+11.97%) |
Filing History |
| 2023-02-14 10:05 am Purchase |
2022-10-31 | 13G | Immunocore Holdings plc IMCR |
RTW Investments, LP | 5,559,322 12.300% |
5,559,322 (New Position) |
Filing History |
| 2023-02-14 10:04 am Purchase |
2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW Investments, LP | 4,993,279 9.600% |
1,126,407 (+29.13%) |
Filing History |
| 2023-02-14 10:04 am Purchase |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
RTW Investments, LP | 3,591,986 7.300% |
992,164 (+38.16%) |
Filing History |
| 2023-02-14 10:04 am Sale |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
RTW Investments, LP | 0 0.000% |
-2,637,192 (Position Closed) |
Filing History |
| 2023-02-14 10:03 am Purchase |
2022-12-31 | 13G | Establishment Labs Holdings Inc. ESTA |
RTW Investments, LP | 2,374,138 9.800% |
55,000 (+2.37%) |
Filing History |
| 2023-02-14 10:02 am Purchase |
2022-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
RTW Investments, LP | 5,615,387 7.700% |
321,421 (+6.07%) |
Filing History |
| 2023-02-14 10:02 am Purchase |
2022-12-31 | 13G | CUTERA INC CUTRQ |
RTW Investments, LP | 1,798,675 9.200% |
401,612 (+28.75%) |
Filing History |
| 2023-02-14 10:01 am Sale |
2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
RTW Investments, LP | 5,741,939 9.300% |
-68,201 (-1.17%) |
Filing History |
| 2023-02-14 10:01 am Purchase |
2022-12-31 | 13G | Exagen Inc. XGN |
RTW Investments, LP | 1,364,336 8.400% |
542,922 (+66.10%) |
Filing History |
| 2023-02-14 10:01 am Purchase |
2022-12-31 | 13G | Adicet Bio, Inc. ACET |
RTW Investments, LP | 4,241,472 9.900% |
1,217,728 (+40.27%) |
Filing History |
| 2023-02-14 10:00 am Sale |
2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
RTW Investments, LP | 0 0.000% |
-2,120,760 (Position Closed) |
Filing History |
| 2023-02-02 4:15 pm Purchase |
2022-09-01 | 13D | Avidity Biosciences, Inc. RNA |
RTW Investments, LP | 5,956,558 9.000% |
1,961,558 (+49.10%) |
Filing History |
| 2023-01-27 5:10 pm Purchase |
2022-01-24 | 13D | Orchestra BioMed Holdings, Inc. OBIO |
RTW Investments, LP | 5,118,512 16.200% |
5,118,512 (New Position) |
Filing History |